Ernst & Young
-
Report: Sales, financing slow down for medtech firms
The industry faces challenges from inflation to labor shortages, according to an annual report from EY. However, there are grounds for optimism and areas to focus on, such as patching up supply chains.
-
Devices & Diagnostics, Health Tech
Report: Medtech M&A jumps as companies bounce back from the pandemic
Medical technology companies saw 288 deals between June 2020 and June 2021, the highest amount ever since Ernst & Young began tracking it in 2007. VC funding in medtech also reached a high point of $9.1 billion.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Healthcare organizations are advancing their tech initiatives in these areas
An EY survey of 347 physicians and healthcare executives found respondents have undertaken staff satisfaction-related projects and are planning initiatives around analytics.
-
What are healthcare organizations’ biggest challenges this year?
Hospitals and health systems face multiple challenges as they transition away from fee-for-service models and toward value-based care. A new survey from EY dug deeper into this issue.
-
#BIO2017 kicks off with a new report highlighting the industry’s resilience
Despite reimbursement, regulatory, and political uncertainty, the global biotech industry held steady in 2016, according to a new report by professional services firm EY (formerly Ernst & Young).
-
5 must-read stories this week: Biotech boom slows, J-Law to play Elizabeth Holmes
Plus, coverage of BIO 2016, progress on health IT interoperability and a fundraise for a concierge care startup.
-
Is the biotech boom slowing down?
As Ernst & Young noted on several occasions, the biotech sector has matured and must now face adult problems.
-
Devices & Diagnostics, Startups
EY Report: With early stage investing stifled, things look grim for the medical device industry
The lack of innovation in the medical device industry can be attributed to the lessening dollars being funneled into startups, a new report from Ernst & Young says.
-
Big Pharma’s big pinch: a $50 billion “growth gap” and fierce M&A competition
Diminished resources and fierce competition from growing biotech and specialty pharma companies will drive smaller […]
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
LifeScience Alley conference kicks off amid storm, both literal and figurative
The medical device industry, long the backbone of Minnesota’s high tech economy, faces perhaps its most challenging environment in decades. From regulatory headaches and health care reform to a dearth of venture capital, medical device stakeholders face a swirling mix of uncertainty and anxiety.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
